Temozolomide for immunomodulation in the treatment of glioblastoma
Sign Up to like & getrecommendations! Published in 2018 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noy072
Abstract: Temozolomide is the most widely used chemotherapy for patients with glioblastoma (GBM) despite the fact that approximately half of treated patients have temozolomide resistance and all patients eventually fail therapy. Due to the limited efficacy… read more here.
Keywords: treatment glioblastoma; immunomodulation treatment; treatment; temozolomide immunomodulation ... See more keywords